Advanced Medical Isotope Debt to Equity Ratio 2013-2024 | RDGL
Current and historical debt to equity ratio values for Advanced Medical Isotope (RDGL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Advanced Medical Isotope debt/equity for the three months ending June 30, 2024 was 0.00.
Advanced Medical Isotope Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-06-30 |
$0.00B |
$0.00B |
0.10 |
2024-03-31 |
$0.00B |
$0.00B |
0.06 |
2023-12-31 |
$0.00B |
$0.00B |
0.18 |
2023-09-30 |
$0.00B |
$0.00B |
0.07 |
2023-06-30 |
$0.00B |
$0.00B |
0.07 |
2023-03-31 |
$0.00B |
$0.00B |
0.04 |
2022-12-31 |
$0.00B |
$0.00B |
0.05 |
2022-09-30 |
$0.00B |
$0.00B |
0.09 |
2022-06-30 |
$0.00B |
$0.00B |
0.24 |
2022-03-31 |
$0.00B |
$0.00B |
0.07 |
2021-12-31 |
$0.00B |
$0.00B |
0.11 |
2021-09-30 |
$0.00B |
$0.00B |
0.44 |
2021-06-30 |
$0.00B |
$0.00B |
0.37 |
2021-03-31 |
$0.00B |
$0.00B |
0.38 |
2020-12-31 |
$0.00B |
$0.00B |
28.30 |
2020-09-30 |
$0.00B |
$-0.00B |
-1.07 |
2020-06-30 |
$0.00B |
$-0.00B |
-1.38 |
2020-03-31 |
$0.00B |
$-0.00B |
-1.01 |
2019-12-31 |
$0.00B |
$-0.00B |
-1.03 |
2019-09-30 |
$0.00B |
$-0.00B |
-1.17 |
2019-06-30 |
$0.00B |
$-0.00B |
-1.04 |
2019-03-31 |
$0.00B |
$-0.00B |
-1.06 |
2018-12-31 |
$0.00B |
$-0.00B |
-1.02 |
2018-09-30 |
$0.04B |
$-0.04B |
-1.00 |
2018-06-30 |
$0.01B |
$-0.01B |
-1.00 |
2018-03-31 |
$0.01B |
$-0.01B |
-1.00 |
2017-12-31 |
$0.00B |
$-0.00B |
-1.00 |
2017-09-30 |
$0.00B |
$-0.00B |
-1.01 |
2017-06-30 |
$0.00B |
$-0.00B |
-1.12 |
2017-03-31 |
$0.00B |
$-0.00B |
-1.01 |
2016-12-31 |
$0.00B |
$-0.00B |
-1.01 |
2016-09-30 |
$0.00B |
$-0.00B |
-1.02 |
2016-06-30 |
$0.01B |
$-0.01B |
-1.02 |
2016-03-31 |
$0.01B |
$-0.01B |
-1.02 |
2015-12-31 |
$0.01B |
$-0.01B |
-1.03 |
2015-09-30 |
$0.01B |
$-0.01B |
-1.01 |
2015-06-30 |
$0.02B |
$-0.02B |
-1.01 |
2015-03-31 |
$0.02B |
$-0.02B |
-1.00 |
2014-12-31 |
$0.02B |
$-0.02B |
-1.00 |
2014-09-30 |
$0.01B |
$-0.01B |
-1.02 |
2014-06-30 |
$0.01B |
$-0.01B |
-1.03 |
2014-03-31 |
$0.01B |
$-0.01B |
-1.03 |
2013-12-31 |
$0.01B |
$-0.01B |
-1.02 |
2013-09-30 |
$0.01B |
$-0.01B |
-1.06 |
2013-06-30 |
$0.01B |
$-0.01B |
-1.06 |
2013-03-31 |
$0.01B |
$-0.01B |
-1.09 |
2012-12-31 |
$0.01B |
$-0.01B |
-1.12 |
2012-09-30 |
$0.00B |
$0.00B |
0.00 |
2012-06-30 |
$0.00B |
$0.00B |
0.00 |
2012-03-31 |
$0.00B |
$0.00B |
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Finance |
Finance - SBIC & Commercial |
$0.049B |
$0.000B |
Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.
|